US 12,240,822 B2
Naphthalene isoxazoline compound and application thereof
Zhitao Lv, Shandong (CN); Zhen Jiang, Shandong (CN); Ting Nie, Shandong (CN); Xingmin Lu, Shandong (CN); Zhongjie Liu, Shandong (CN); Songzhi Yao, Shandong (CN); and Yan Cao, Shandong (CN)
Assigned to SHANDONG CHENGCHUANG BLUE SEA PHARMACEUTICAL TECHNOLOGY CO., LTD., Shandong (CN)
Filed by SHANDONG CHENGCHUANG BLUE SEA PHARMACEUTICAL TECHNOLOGY CO., LTD., Shandong (CN); and Zhitao Lv, Shandong (CN)
Filed on Aug. 29, 2024, as Appl. No. 18/820,199.
Application 18/820,199 is a continuation of application No. PCT/CN2023/103946, filed on Jun. 29, 2023.
Claims priority of application No. 202310070589.1 (CN), filed on Jan. 16, 2023.
Prior Publication US 2024/0425468 A1, Dec. 26, 2024
Int. Cl. C07D 261/04 (2006.01); A01N 43/80 (2006.01); A01P 7/02 (2006.01); A01P 7/04 (2006.01)
CPC C07D 261/04 (2013.01) [A01N 43/80 (2013.01); A01P 7/02 (2021.08); A01P 7/04 (2021.08)] 10 Claims
 
1. A naphthalene isoxazoline compound, or a chiral monomer or mixture thereof, or a cis-trans isomer monomer or mixture thereof, or an agrichemically acceptable salt, hydrate or solvate thereof, wherein the compound is 4-(5-(3-chloro-5-(trifluoromethyl)phenyl)-5-(trifluoromethyl)-4,5-dihydroisoxazol-3-yl)-N-((methoxylimino)methyl)-1-naphthylformamide, and has the structure shown in Formula (I):

OG Complex Work Unit Chemistry